Suppr超能文献

丝氨酸蛋白酶抑制剂 2 通过激活骨形态发生蛋白 4 促进食管鳞癌细胞转移。

SERPINE2 promotes esophageal squamous cell carcinoma metastasis by activating BMP4.

机构信息

State Key Laboratory of Molecular Oncology, National Cancer Center/ National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China.

State Key Laboratory of Molecular Oncology, National Cancer Center/ National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China.

出版信息

Cancer Lett. 2020 Jan 28;469:390-398. doi: 10.1016/j.canlet.2019.11.011. Epub 2019 Nov 12.

Abstract

Metastasis is a major lethal cause of esophageal squamous cell carcinoma (ESCC) and confers a poor prognosis. Previous studies demonstrated that serpin family E member 2 (SERPINE2) is involved in tumor metastasis. However, the function and mechanism of SERPINE2 in ESCC metastasis remains unclear. In this study, we found that SERPINE2 was increased in ESCC and associated with tumor metastasis. SERPINE2 knockdown inhibited tumor cell invasion and lymph node and lung metastasis by inducing epithelial-mesenchymal transition (EMT). We identified a total of 410 differentially expressed genes in SERPINE2-knockdown cells by RNA-Seq analysis. Among them, bone morphogenetic protein 4 (BMP4) was significantly downregulated. Conversely, BMP4 was increased in SERPINE2-overexpressing cells. Inhibiting BMP4 could attenuate SERPINE2-induced migration and invasion. Moreover, SERPINE2 was positively correlated with clinical stage, tumor invasion depth and lymph node metastasis in ESCC patients. These findings suggest that SERPINE2 promotes tumor metastasis by activating BMP4 and could serve as a potential therapeutic target for clinical intervention in ESCC.

摘要

转移是食管鳞状细胞癌(ESCC)的主要致死原因,并导致预后不良。先前的研究表明,丝氨酸蛋白酶抑制剂家族 E 成员 2(SERPINE2)参与肿瘤转移。然而,SERPINE2 在 ESCC 转移中的功能和机制尚不清楚。在这项研究中,我们发现 SERPINE2 在 ESCC 中增加,并与肿瘤转移相关。SERPINE2 敲低通过诱导上皮-间充质转化(EMT)抑制肿瘤细胞侵袭、淋巴结和肺转移。通过 RNA-Seq 分析,我们在 SERPINE2 敲低细胞中总共鉴定出 410 个差异表达基因。其中,骨形态发生蛋白 4(BMP4)显著下调。相反,BMP4 在 SERPINE2 过表达细胞中增加。抑制 BMP4 可以减弱 SERPINE2 诱导的迁移和侵袭。此外,SERPINE2 与 ESCC 患者的临床分期、肿瘤浸润深度和淋巴结转移呈正相关。这些发现表明,SERPINE2 通过激活 BMP4 促进肿瘤转移,可作为 ESCC 临床干预的潜在治疗靶点。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验